Published in Eur J Pediatr on May 22, 2007
New surfactant with SP-B and C analogs gives survival benefit after inactivation in preterm lambs. PLoS One (2012) 0.98
Clinical practice : noninvasive respiratory support in newborns. Eur J Pediatr (2010) 0.96
Drug utilisation on a preterm and neonatal intensive care unit in Germany: a prospective, cohort-based analysis. Eur J Clin Pharmacol (2009) 0.96
Activation of the liver X receptor prevents lipopolysaccharide-induced lung injury. J Biol Chem (2009) 0.90
Meconium impairs pulmonary surfactant by a combined action of cholesterol and bile acids. Biophys J (2011) 0.85
Mechanisms of polyelectrolyte enhanced surfactant adsorption at the air-water interface. Biochim Biophys Acta (2009) 0.84
Bronchoalveolar lavage with pulmonary surfactant/dextran mixture improves meconium clearance and lung functions in experimental meconium aspiration syndrome. Eur J Pediatr (2007) 0.82
The effect of a C-terminal peptide of surfactant protein B (SP-B) on oriented lipid bilayers, characterized by solid-state 2H- and 31P-NMR. Biophys J (2009) 0.79
Early surfactant therapy with nasal continuous positive airway pressure or continued mechanical ventilation in very low birth weight neonates with respiratory distress syndrome. Iran Red Crescent Med J (2014) 0.78
Chorioamnionitis and lung injury in preterm newborns. Crit Care Res Pract (2013) 0.75
Optimization of Variable Ventilation for Physiology, Immune Response and Surfactant Enhancement in Preterm Lambs. Front Physiol (2017) 0.75
Surface properties in relation to atelectasis and hyaline membrane disease. AMA J Dis Child (1959) 7.97
Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. Am J Respir Crit Care Med (2002) 4.66
ABCA3 gene mutations in newborns with fatal surfactant deficiency. N Engl J Med (2004) 4.64
Immunoregulatory functions of surfactant proteins. Nat Rev Immunol (2005) 4.55
Brief report: deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis. N Engl J Med (1993) 3.33
Effect of exogenous surfactant (calfactant) in pediatric acute lung injury: a randomized controlled trial. JAMA (2005) 3.29
Artificial surfactant therapy in hyaline-membrane disease. Lancet (1980) 3.21
Multicenter study of surfactant (beractant) use in the treatment of term infants with severe respiratory failure. Survanta in Term Infants Study Group. J Pediatr (1998) 2.64
ABCA3 mutations associated with pediatric interstitial lung disease. Am J Respir Crit Care Med (2005) 2.52
Interstitial lung disease in a baby with a de novo mutation in the SFTPC gene. Eur Respir J (2004) 2.26
Variables associated with the early failure of nasal CPAP in very low birth weight infants. J Pediatr (2005) 2.25
Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev (2001) 2.04
Identification of LBM180, a lamellar body limiting membrane protein of alveolar type II cells, as the ABC transporter protein ABCA3. J Biol Chem (2002) 1.92
Is it safer to intubate premature infants in the delivery room? Pediatrics (2005) 1.81
A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome. Pediatrics (2005) 1.80
A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants. Am J Perinatol (2004) 1.75
ABCA3 is a lamellar body membrane protein in human lung alveolar type II cells. FEBS Lett (2001) 1.71
A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants. Pediatrics (2005) 1.70
Surfactant protein C biosynthesis and its emerging role in conformational lung disease. Annu Rev Physiol (2005) 1.65
Technique for intrapartum administration of surfactant without requirement for an endotracheal tube. J Perinatol (2004) 1.62
Efficacy of interventions for bronchiolitis in critically ill infants: a systematic review and meta-analysis. Pediatr Crit Care Med (2004) 1.62
Randomised clinical trial of two treatment regimens of natural surfactant preparations in neonatal respiratory distress syndrome. Arch Dis Child Fetal Neonatal Ed (1995) 1.60
Instillation of calf lung surfactant extract (calfactant) is beneficial in pediatric acute hypoxemic respiratory failure. Members of the Mid-Atlantic Pediatric Critical Care Network. Crit Care Med (1999) 1.59
Calf's lung surfactant extract in acute hypoxemic respiratory failure in children. Crit Care Med (1996) 1.59
Surfactant therapy in full-term neonates with severe respiratory failure. Pediatrics (1993) 1.57
Comparison of three treatment regimens of natural surfactant preparations in neonatal respiratory distress syndrome. Eur J Pediatr (2003) 1.57
Aberrant processing of surfactant protein C in hereditary SP-B deficiency. Am J Physiol (1995) 1.55
A multicenter, randomized, controlled trial comparing Surfaxin (Lucinactant) lavage with standard care for treatment of meconium aspiration syndrome. Pediatrics (2002) 1.54
Surfactant (beractant) therapy for infants with congenital diaphragmatic hernia on ECMO: evidence of persistent surfactant deficiency. J Pediatr Surg (1994) 1.54
Early surfactant for neonates with mild to moderate respiratory distress syndrome: a multicenter, randomized trial. J Pediatr (2004) 1.53
Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev (2000) 1.52
Genetic polymorphism of the binding domain of surfactant protein-A2 increases susceptibility to meningococcal disease. Clin Infect Dis (2006) 1.51
Functional and trafficking defects in ATP binding cassette A3 mutants associated with respiratory distress syndrome. J Biol Chem (2006) 1.49
Synthetic surfactants: the search goes on. Pediatrics (2005) 1.45
In defense of the lung: surfactant protein A and surfactant protein D. Curr Opin Pharmacol (2006) 1.44
The CDH Study Group and advances in the clinical care of the patient with congenital diaphragmatic hernia. Semin Perinatol (2004) 1.44
Deletion of exon 4 from human surfactant protein C results in aggresome formation and generation of a dominant negative. J Cell Sci (2003) 1.44
Treatment with exogenous surfactant stimulates endogenous surfactant synthesis in premature infants with respiratory distress syndrome. Crit Care Med (2000) 1.43
Surfactant replacement therapy for meconium aspiration syndrome. Pediatrics (1996) 1.42
Allelic heterogeneity in hereditary surfactant protein B (SP-B) deficiency. Am J Respir Crit Care Med (2000) 1.42
Surfactant phosphatidylcholine pool size in human neonates with congenital diaphragmatic hernia requiring ECMO. J Pediatr (2003) 1.41
Adaptation and increased susceptibility to infection associated with constitutive expression of misfolded SP-C. J Cell Biol (2006) 1.41
Mutation of SFTPC in infantile pulmonary alveolar proteinosis with or without fibrosing lung disease. Am J Med Genet A (2004) 1.39
Surfactant composition and function in patients with ABCA3 mutations. Pediatr Res (2006) 1.37
Surfactant protein deficiency in familial interstitial lung disease. J Pediatr (2001) 1.37
Nonspecific interstitial pneumonia and usual interstitial pneumonia with mutation in surfactant protein C in familial pulmonary fibrosis. Mod Pathol (2004) 1.37
ABCA3 inactivation in mice causes respiratory failure, loss of pulmonary surfactant, and depletion of lung phosphatidylglycerol. J Lipid Res (2006) 1.35
A common mutation in the surfactant protein C gene associated with lung disease. J Pediatr (2005) 1.31
Alteration of the pulmonary surfactant system in full-term infants with hereditary ABCA3 deficiency. Am J Respir Crit Care Med (2006) 1.30
Timing of initial surfactant treatment for infants 23 to 29 weeks' gestation: is routine practice evidence based? Pediatrics (2004) 1.28
Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev (2004) 1.23
Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome. Cochrane Database Syst Rev (2001) 1.22
Human ABCA3, a product of a responsible gene for abca3 for fatal surfactant deficiency in newborns, exhibits unique ATP hydrolysis activity and generates intracellular multilamellar vesicles. Biochem Biophys Res Commun (2004) 1.20
Characterization and classification of ATP-binding cassette transporter ABCA3 mutants in fatal surfactant deficiency. J Biol Chem (2006) 1.20
A recombinant trimeric surfactant protein D carbohydrate recognition domain inhibits respiratory syncytial virus infection in vitro and in vivo. Eur J Immunol (1999) 1.16
Early extubation and nasal continuous positive airway pressure after surfactant treatment for respiratory distress syndrome among preterm infants <30 weeks' gestation. Pediatrics (2004) 1.13
Reversibility of lung inflammation caused by SP-B deficiency. Am J Physiol Lung Cell Mol Physiol (2005) 1.11
Clinical course of premature infants intubated in the delivery room, submitted or not to porcine-derived lung surfactant therapy within the first hour of life. J Matern Fetal Neonatal Med (2003) 1.11
Antimicrobial activity of native and synthetic surfactant protein B peptides. J Immunol (2006) 1.10
Surfactant treatment of full-term newborns with respiratory failure. Pediatrics (1991) 1.10
Surfactant protein C gene variation in the Finnish population - association with perinatal respiratory disease. Eur J Hum Genet (2004) 1.09
Data mining and multiparameter analysis of lung surfactant protein genes in bronchopulmonary dysplasia. Hum Mol Genet (2004) 1.09
Surfactant protein C: its unique properties and emerging immunomodulatory role in the lung. Microbes Infect (2006) 1.09
Hydroxychloroquine and surfactant protein C deficiency. N Engl J Med (2005) 1.07
Surfactant treatment of neonates with respiratory failure and group B streptococcal infection. Members of the Collaborative European Multicenter Study Group. Pediatrics (2000) 1.07
Lung transplantation for treatment of infants with surfactant protein B deficiency. J Pediatr (1997) 1.06
Surfactant proteins A and B as interactive genetic determinants of neonatal respiratory distress syndrome. Hum Mol Genet (2000) 1.05
Surfactant protein B inhibits endotoxin-induced lung inflammation. Am J Respir Cell Mol Biol (2003) 1.05
ATP-binding cassette (ABC) transporters in human metabolism and diseases. Physiol Res (2004) 1.05
Long-term outcomes after infant lung transplantation for surfactant protein B deficiency related to other causes of respiratory failure. J Pediatr (2006) 1.03
Comparison of Infasurf (calf lung surfactant extract) to Survanta (Beractant) in the treatment and prevention of respiratory distress syndrome. Pediatrics (1997) 1.01
Laryngeal mask airway used as a delivery conduit for the administration of surfactant to preterm infants with respiratory distress syndrome. Biol Neonate (2005) 1.01
Is surfactant therapy beneficial in the treatment of the term newborn infant with congenital diaphragmatic hernia? J Pediatr (2004) 1.01
Chitosan enhances the in vitro surface activity of dilute lung surfactant preparations and resists albumin-induced inactivation. Pediatr Res (2006) 1.00
Biosynthesis of surfactant protein C: characterization of aggresome formation by EGFP chimeras containing propeptide mutants lacking conserved cysteine residues. J Cell Sci (2001) 0.99
Inherited surfactant protein-B deficiency and surfactant protein-C associated disease: clinical features and evaluation. Semin Perinatol (2006) 0.99
A randomized trial comparing beractant and poractant treatment in neonatal respiratory distress syndrome. Acta Paediatr (2005) 0.99
Treatment with bovine surfactant in severe acute respiratory distress syndrome in children: a randomized multicenter study. Intensive Care Med (2003) 0.99
Surfactant protein-A gene locus associated with recurrent otitis media. J Pediatr (2001) 0.98
Surfactant does not improve survival rate in preterm infants with congenital diaphragmatic hernia. J Pediatr Surg (2004) 0.97
Inhibition of pulmonary surfactant function by meconium. Am J Obstet Gynecol (1991) 0.95
ABCA3 deficiency: neonatal respiratory failure and interstitial lung disease. Semin Perinatol (2006) 0.95
Hyaluronan reduces surfactant inhibition and improves rat lung function after meconium injury. Pediatr Res (2005) 0.94
Hyaluronan decreases surfactant inactivation in vitro. Pediatr Res (2004) 0.93
Surfactant therapy for bronchiolitis in critically ill infants. Cochrane Database Syst Rev (2006) 0.92
Surfactant replacement therapy for severe neonatal respiratory distress syndrome: an international randomized clinical trial. Collaborative European Multicenter Study Group. Pediatrics (1988) 0.92
Genetic basis of respiratory distress syndrome. Front Biosci (2007) 0.91
A recombinant fragment of human SP-D reduces allergic responses in mice sensitized to house dust mite allergens. Clin Exp Immunol (2003) 0.91
Morphology and function of pulmonary surfactant inhibited by meconium. Pediatr Res (1998) 0.90
A dual stable isotope tracer method for the measurement of surfactant disaturated-phosphatidylcholine net synthesis in infants with congenital diaphragmatic hernia. Pediatr Res (2004) 0.90
Surfactant application during extracorporeal membrane oxygenation improves lung volume and pulmonary mechanics in children with respiratory failure. Crit Care (2005) 0.90
Surfactant therapy in neonates with respiratory failure due to haemorrhagic pulmonary oedema. Eur J Pediatr (2003) 0.89
Bile salt-induced intracellular Ca++ accumulation in type II pneumocytes. Lung (1990) 0.89
Pathophysiology of congenital diaphragmatic hernia. III: Exogenous surfactant therapy for the high-risk neonate with CDH. J Pediatr Surg (1992) 0.89
Pathophysiology of congenital diaphragmatic hernia. V. Effect of exogenous surfactant therapy on gas exchange and lung mechanics in the lamb congenital diaphragmatic hernia model. J Pediatr (1994) 0.89
Surfactant improves oxygenation in infants and children with pneumonia and acute respiratory distress syndrome. Acta Paediatr (2002) 0.88
Protective effects of a recombinant fragment of human surfactant protein D in a murine model of pulmonary hypersensitivity induced by dust mite allergens. Immunol Lett (2003) 0.88
Resistance of different surfactant preparations to inactivation by meconium. Pediatr Res (2001) 0.87
Intratracheal recombinant surfactant protein d prevents endotoxin shock in the newborn preterm lamb. Am J Respir Crit Care Med (2006) 0.87
Population pharmacokinetics and dosing of amoxicillin in (pre)term neonates. Ther Drug Monit (2006) 1.51
Non-invasive markers for early diagnosis and determination of the severity of necrotizing enterocolitis. Ann Surg (2010) 1.49
Illness severity and parental permission for clinical research in a pediatric ICU population. Intensive Care Med (2005) 1.48
Surfactant phosphatidylcholine pool size in human neonates with congenital diaphragmatic hernia requiring ECMO. J Pediatr (2003) 1.41
Histologic chorioamnionitis, fetal involvement, and antenatal steroids: effects on neonatal outcome in preterm infants. Am J Obstet Gynecol (2009) 1.18
Endotoxin induced chorioamnionitis prevents intestinal development during gestation in fetal sheep. PLoS One (2009) 1.17
Metabolomics of volatile organic compounds in cystic fibrosis patients and controls. Pediatr Res (2010) 1.16
The effect of cumulative energy and protein deficiency on anthropometric parameters in a pediatric ICU population. Clin Nutr (2004) 1.10
Chorioamnionitis as a risk factor for necrotizing enterocolitis: a systematic review and meta-analysis. J Pediatr (2012) 1.07
Classification of respiratory disease after preterm birth. J Pediatr (2013) 1.07
Clinical practice : noninvasive respiratory support in newborns. Eur J Pediatr (2010) 0.96
Chlamydia trachomatis and placental inflammation in early preterm delivery. Eur J Epidemiol (2011) 0.94
Pharmacokinetics of intravenous rifampicin (rifampin) in neonates. Ther Drug Monit (2006) 0.92
Early increased levels of matrix metalloproteinase-9 in neonates recovering from respiratory distress syndrome. Biol Neonate (2005) 0.91
A dual stable isotope tracer method for the measurement of surfactant disaturated-phosphatidylcholine net synthesis in infants with congenital diaphragmatic hernia. Pediatr Res (2004) 0.90
Routine procedures in NICUs: factors influencing pain assessment and ranking by pain intensity. Swiss Med Wkly (2008) 0.87
Surfactant synthesis and kinetics in infants with congenital diaphragmatic hernia. Am J Respir Crit Care Med (2002) 0.86
Vasoactivity of the gasotransmitters hydrogen sulfide and carbon monoxide in the chicken ductus arteriosus. Am J Physiol Regul Integr Comp Physiol (2011) 0.84
Metabolic kinetics of pulmonary surfactant in newborn infants using endogenous stable isotope techniques. J Lipid Res (2005) 0.83
Metabolomic analysis of bronchoalveolar lavage fluid in preterm infants complicated by respiratory distress syndrome: preliminary results. J Matern Fetal Neonatal Med (2011) 0.83
Population pharmacokinetics and dosing of flucloxacillin in preterm and term neonates. Ther Drug Monit (2006) 0.83
Repeated intrauterine exposures to inflammatory stimuli attenuated transforming growth factor-β signaling in the ovine fetal lung. Neonatology (2013) 0.82
Pulmonary surfactant disaturated-phosphatidylcholine (DSPC) turnover and pool size in newborn infants with congenital diaphragmatic hernia (CDH). Pediatr Res (2003) 0.82
Lipopolysaccharide-induced chorioamnionitis is confined to one amniotic compartment in twin pregnant sheep. Neonatology (2012) 0.82
Thrombin contributes to bronchoalveolar lavage fluid mitogenicity in lung disease of the premature infant. Pediatr Pulmonol (2003) 0.82
Surfactant kinetics in preterm infants on mechanical ventilation who did and did not develop bronchopulmonary dysplasia. Crit Care Med (2003) 0.81
Early postnatal blood pressure in preterm infants: effects of chorioamnionitis and timing of antenatal steroids. Pediatr Res (2009) 0.81
Albumin synthesis in preterm infants on the first day of life studied with [1-13C]leucine. Am J Physiol Gastrointest Liver Physiol (2007) 0.81
Preconception care: preliminary estimates of costs and effects of smoking cessation and folic acid supplementation. J Reprod Med (2004) 0.81
Intravenous lipopolysaccharide-induced pulmonary maturation and structural changes in fetal sheep. Am J Obstet Gynecol (2008) 0.80
In utero and early-life conditions and adult health and disease. N Engl J Med (2008) 0.80
Pulmonary vascular endothelial growth factor expression and disaturated phospholipid content in a chicken model of hypoxia-induced fetal growth restriction. Neonatology (2009) 0.79
S100B urine concentrations in late preterm infants are gestational age and gender dependent. Clin Chim Acta (2012) 0.79
Genomic alterations in human umbilical cord-derived mesenchymal stromal cells call for stringent quality control before any possible therapeutic approach. Cytotherapy (2013) 0.79
The role of initial monitoring of routine biochemical nutritional markers in critically ill children. J Nutr Biochem (2005) 0.78
Comparison of recruitment manoeuvres in ventilated sheep with acute respiratory distress syndrome. Lung (2012) 0.78
Protein binding of flucloxacillin in neonates. Ther Drug Monit (2007) 0.78
Effects of in utero endotoxemia on the ovine fetal brain: a model for schizophrenia? Front Biosci (Elite Ed) (2012) 0.77
[From classic to new bronchopulmonary dysplasia]. Ned Tijdschr Geneeskd (2010) 0.77
The endocrine system in treated patients with classical galactosemia. Mol Genet Metab (2006) 0.77
Perinatal asphyxia: kidney failure does not affect S100B urine concentrations. Clin Chim Acta (2011) 0.77
Surfactant phosphatidylcholine half-life and pool size measurements in premature baboons developing bronchopulmonary dysplasia. Pediatr Res (2002) 0.77
Fetal asphyctic preconditioning protects against perinatal asphyxia- induced apoptosis and astrogliosis in neonatal brain. CNS Neurol Disord Drug Targets (2015) 0.77
Bronchoalveolar lavage fluid from preterm infants with chorioamnionitis inhibits alveolar epithelial repair. Respir Res (2009) 0.77
Fetal brain genomic reprogramming following asphyctic preconditioning. BMC Neurosci (2013) 0.77
Elevated Activin A urine levels are predictors of intraventricular haemorrhage in preterm newborns. Acta Paediatr (2013) 0.76
Automated auditory brainstem response in preterm newborns with histological chorioamnionitis. J Matern Fetal Neonatal Med (2014) 0.76
A clinical prediction rule for histological chorioamnionitis in preterm newborns. PLoS One (2012) 0.76
Why partial liquid ventilation did not fulfill its promise. Am J Respir Crit Care Med (2006) 0.76
Chorioamnionitis induced hepatic inflammation and disturbed lipid metabolism in fetal sheep. Pediatr Res (2010) 0.76
Dissociation of transforming growth factors β1 and β2 from surfactant protein A (SP-A) by deglycosylation or deoxycholate treatment. J Immunol Methods (2011) 0.76
The effects of dexamethasone and oxygen in ventilated adult sheep with early phase acute respiratory distress syndrome. Lung (2014) 0.75
Fetal asphyctic preconditioning alters the transcriptional response to perinatal asphyxia. BMC Neurosci (2014) 0.75
A pilot study of a practice management training module for medical residents. BMC Med Educ (2014) 0.75
Surfactant protein A influences reepithelialization in an alveolocapillary model system. Lung (2012) 0.75
Alveolocapillary model system to study alveolar re-epithelialization. Exp Cell Res (2012) 0.75
Urine S100 BB and A1B dimers are valuable predictors of adverse outcome in full-term asphyxiated infants. Acta Paediatr (2013) 0.75
Change in total body water as a predictive tool for growth hormone treatment response. Horm Res Paediatr (2012) 0.75
Massive bacterial cell invasion and reactive type II pneumocytes in bronchoalveolar lavage fluid from a preterm neonate. Arch Dis Child Fetal Neonatal Ed (2007) 0.75
N-SIPPV versus bi-level N-CPAP for early treatment of respiratory distress syndrome in preterm infants. J Matern Fetal Neonatal Med (2013) 0.75
S100B protein maternal and fetal bloodstreams gradient in healthy and small for gestational age pregnancies. Clin Chim Acta (2011) 0.75
Surfactant protein A binds TGF-β1 with high affinity and stimulates the TGF-β pathway. Innate Immun (2013) 0.75
Italia-Netherland PhD Program: the I.O. PhD Research Program. J Matern Fetal Neonatal Med (2011) 0.75